PCDHGB7CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。PCDHGB7遺伝子サイレンサーは、PCDHGB7 CRISPR/Cas9ノックアウトプラスミドとPCDHGB7Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のPCDHGB7CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
PCDHGB7 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCDHGB7 CRISPR/Cas9 KOプラスミド (h) | sc-410039 | h | Gene Knockout | GFP | 0 | ||
PCDHGB7 HDRプラスミド (h) | sc-410039-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCDHGB7 Double Nickaseプラスミド (h) | sc-410039-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCDHGB7 Double Nickaseプラスミド (h2) | sc-410039-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Pcdhgb7 CRISPR/Cas9 KOプラスミド (m) | sc-430013 | m | Gene Knockout | GFP | 0 | ||
Pcdhgb7 HDRプラスミド (m) | sc-430013-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgb7 Double Nickaseプラスミド (m) | sc-430013-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb7 Double Nickaseプラスミド (m2) | sc-430013-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb8 CRISPR/Cas9 KOプラスミド (m) | sc-430014 | m | Gene Knockout | GFP | 0 | ||
Pcdhgb8 HDRプラスミド (m) | sc-430014-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Pcdhgb8 Double Nickaseプラスミド (m) | sc-430014-NIC | m | Gene Knockout | Puromycin | 0 | ||
Pcdhgb8 Double Nickaseプラスミド (m2) | sc-430014-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PCDHGB7 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PCDHGB7 CRISPR Activationプラスミド (h) | sc-410039-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 CRISPR Activationプラスミド (h2) | sc-410039-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 Lentiviral Activation Particles (h) | sc-410039-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCDHGB7 Lentiviral Activation Particles (h2) | sc-410039-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 CRISPR Activationプラスミド (m) | sc-430013-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 CRISPR Activationプラスミド (m2) | sc-430013-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 Lentiviral Activation Particles (m) | sc-430013-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb7 Lentiviral Activation Particles (m2) | sc-430013-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 CRISPR Activationプラスミド (m) | sc-430014-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 CRISPR Activationプラスミド (m2) | sc-430014-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 Lentiviral Activation Particles (m) | sc-430014-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Pcdhgb8 Lentiviral Activation Particles (m2) | sc-430014-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |